Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups
Annals of Internal Medicine · 2026
DOI: 10.7326/annals-25-00464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine, 2026. Verfasst von Chloe C Su und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University School of Medicine, and Quantitative Sciences Unit, Stanford University School …. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Smoking, Eligibility Determination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The U.S. Preventive Services Task Force expanded lung cancer (LC) screening eligibility in 2021 (USPSTF-2021) by decreasing the minimum number of smoking pack-years from 30 to 20. Underrepresented minorities still experience disparities in screening eligibility. OBJECTIVE: To evaluate screening eligibility and prognostic performance of alternative smoking duration-based criteria versus USPSTF-2021 (primary outcome) and risk-based screening using the recalibrated Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2012 (PLCOm2012update) model (secondary outcome) across diverse racial and ethnic groups. DESIGN: Prospective, population-based Multiethnic Cohort linked to SEER (Surveillance, Epidemiology, and End Results) registries. SETTING: California and Hawai'i, with recruitment from 1993 to 1996. PARTICIPANTS: 105 261 adults aged 45 to 75 years with a history of smoking. MEASUREMENTS: Hypothetical eligibility and prognostic performance (sensitivity and specificity) in detecting 6-year LC. RESULTS: Under USPSTF-2021, 24.0% of the cohort would be eligible for screening; a 30-year smoking duration yielded the closest eligibility rate (27.5%). Compared with USPSTF-2021, the 30-year duration criteria would reduce eligibility gaps across all races relative to Whites, most notably in African Americans (30.4% vs. 28.8% for Whites under duration-based; 21.4% vs. 30.2% for Whites under USPSTF-2021) and Latinos (25.1% vs. 28.8% for Whites under duration-based; 15.7% vs. 30.2% for Whites under USPSTF-2021). Prognostic sensitivity to identify LC within 6 years increased across all races under the 30-year duration criteria, although specificity decreased commensurately. At matched overall eligibility (27.5%), a risk-based PLCOm2012update 6-year threshold of 1.1% improved both sensitivity and specificity in the overall cohort. However, it widened the eligibility gap between Latinos and Whites (14.4% vs. 31.3%) and demonstrated lower sensitivity in Latinos than duration-based criteria (59.7% vs. 69.8%). LIMITATIONS: Cohort geography and enrollment period may limit generalizability. Overdiagnosis was not measured. CONCLUSION: Compared with USPSTF-2021, the 30-year duration-based criteria could reduce the eligibility gaps among African Americans and Latinos relative to Whites while improving 6-year LC detection sensitivity across all races. PRIMARY FUNDING SOURCE: National Institutes of Health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Population Health, Stanford University School of Medicine, and Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California (C.C.S.).
- Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California (V.Y.D.).
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (K.t.H.).
- Veterans Affairs Palo Alto Healthcare System, Palo Alto, California (J.T.W.).
- Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (N.D.F.).
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California (L.M.B., N.S.L.).
ORCID-Profile: Chloe C Su, Victoria Y Ding, Kevin Ten Haaf, Julie T Wu, Neal D Freedman, Leah M Backhus, Natalie S Lui, Joel W Neal, Martin C Tammemägi, Heather A Wakelee, Eunji Choi, Summer S Han
Förderung
- HSRD VA
- NCI NIH HHS
Zitieren
APA
Su, C. C., Ding, V. Y., Ten Haaf, K., Wu, J. T., Freedman, N. D., Backhus, L. M., Leung, A. N., Lui, N. S., Haiman, C. A., Park, S. L., Neal, J. W., Meza, R., Tammemägi, M. C., Cheng, I., Le Marchand, L., Wakelee, H. A., Choi, E., & Han, S. S. (2026). Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups. Annals of Internal Medicine. https://doi.org/10.7326/annals-25-00464
Vancouver
Su CC, Ding VY, Ten Haaf K, Wu JT, Freedman ND, Backhus LM, et al. Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups. Annals of Internal Medicine. 2026. doi:10.7326/annals-25-00464
BibTeX
@article{Su2026,
author = {Su, Chloe C and Ding, Victoria Y and Ten Haaf, Kevin and Wu, Julie T and Freedman, Neal D and Backhus, Leah M and Leung, Ann N and Lui, Natalie S and Haiman, Christopher A and Park, Sung-Shim Lani and Neal, Joel W and Meza, Rafael and Tammemägi, Martin C and Cheng, Iona and Le Marchand, Loïc and Wakelee, Heather A and Choi, Eunji and Han, Summer S},
title = {Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups},
journal = {Annals of Internal Medicine},
year = {2026},
doi = {10.7326/annals-25-00464}
}
EUVIMED